PubRank

Angeline S Andrew

Author PubWeight™ 58.38‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium. J Natl Cancer Inst 2010 3.18
2 MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors. J Clin Invest 2010 2.87
3 Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer. Nat Genet 2009 2.76
4 A case-control study of smoking and bladder cancer risk: emergent patterns over time. J Natl Cancer Inst 2009 2.40
5 Implications of LINE1 methylation for bladder cancer risk in women. Clin Cancer Res 2010 2.10
6 Lung cancer in a U.S. population with low to moderate arsenic exposure. Environ Health Perspect 2009 1.77
7 Characterizing genetic interactions in human disease association studies using statistical epistasis networks. BMC Bioinformatics 2011 1.68
8 A computationally efficient hypothesis testing method for epistasis analysis using multifactor dimensionality reduction. Genet Epidemiol 2009 1.61
9 Ecogeographic genetic epidemiology. Genet Epidemiol 2009 1.57
10 International Lung Cancer Consortium: pooled analysis of sequence variants in DNA repair and cell cycle pathways. Cancer Epidemiol Biomarkers Prev 2008 1.51
11 A system-level pathway-phenotype association analysis using synthetic feature random forest. Genet Epidemiol 2014 1.46
12 Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the international consortium of bladder cancer. Cancer Res 2009 1.43
13 Survival following the diagnosis of noninvasive bladder cancer: WHO/International Society of Urological Pathology versus WHO classification systems. J Urol 2007 1.33
14 Enabling personal genomics with an explicit test of epistasis. Pac Symp Biocomput 2010 1.33
15 Analgesic and anti-inflammatory drug use and risk of bladder cancer: a population based case control study. BMC Urol 2007 1.28
16 Previous lung diseases and lung cancer risk: a pooled analysis from the International Lung Cancer Consortium. Am J Epidemiol 2012 1.27
17 Identification of methylated genes associated with aggressive bladder cancer. PLoS One 2010 1.27
18 In-home coal and wood use and lung cancer risk: a pooled analysis of the International Lung Cancer Consortium. Environ Health Perspect 2010 1.17
19 A novel survival multifactor dimensionality reduction method for detecting gene-gene interactions with application to bladder cancer prognosis. Hum Genet 2010 1.14
20 International Lung Cancer Consortium: coordinated association study of 10 potential lung cancer susceptibility variants. Carcinogenesis 2010 1.11
21 Measures of cumulative exposure from a standardized sun exposure history questionnaire: a comparison with histologic assessment of solar skin damage. Am J Epidemiol 2007 1.11
22 Selenium and risk of bladder cancer: a population-based case-control study. Cancer Prev Res (Phila) 2009 1.09
23 A novel pathway for nickel-induced interleukin-8 expression. J Biol Chem 2002 1.08
24 A robust multifactor dimensionality reduction method for detecting gene-gene interactions with application to the genetic analysis of bladder cancer susceptibility. Ann Hum Genet 2010 1.07
25 Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International Lung Cancer Consortium. Eur J Cancer 2012 1.07
26 Role of genetic heterogeneity and epistasis in bladder cancer susceptibility and outcome: a learning classifier system approach. J Am Med Inform Assoc 2013 1.00
27 Asthma and lung cancer risk: a systematic investigation by the International Lung Cancer Consortium. Carcinogenesis 2011 0.99
28 A simple and computationally efficient sampling approach to covariate adjustment for multifactor dimensionality reduction analysis of epistasis. Hum Hered 2010 0.97
29 Exposure to secondhand tobacco smoke and lung cancer by histological type: a pooled analysis of the International Lung Cancer Consortium (ILCCO). Int J Cancer 2014 0.95
30 Methylenetetrahydrofolate reductase (MTHFR) variants and bladder cancer: a population-based case-control study. Int J Hyg Environ Health 2005 0.95
31 A case-control study of polymorphisms in xenobiotic and arsenic metabolism genes and arsenic-related bladder cancer in New Hampshire. Toxicol Lett 2012 0.94
32 EGFR pathway polymorphisms and bladder cancer susceptibility and prognosis. Carcinogenesis 2009 0.92
33 Arsenic-induced decreases in the vascular matrix. Toxicol Pathol 2008 0.92
34 Histological classification and stage of newly diagnosed bladder cancer in a population-based study from the Northeastern United States. Scand J Urol Nephrol 2008 0.92
35 Evidence for the ubiquitin protease UBP43 as an antineoplastic target. Mol Cancer Ther 2012 0.91
36 Body mass and smoking are modifiable risk factors for recurrent bladder cancer. Cancer 2013 0.90
37 Associated Links Among Smoking, Chronic Obstructive Pulmonary Disease, and Small Cell Lung Cancer: A Pooled Analysis in the International Lung Cancer Consortium. EBioMedicine 2015 0.90
38 Aspirin and NSAID use and lung cancer risk: a pooled analysis in the International Lung Cancer Consortium (ILCCO). Cancer Causes Control 2011 0.89
39 Polymorphisms in the XRCC1 gene modify survival of bladder cancer patients treated with chemotherapy. Int J Cancer 2013 0.86
40 SLC39A2 and FSIP1 polymorphisms as potential modifiers of arsenic-related bladder cancer. Hum Genet 2011 0.84
41 Arsenic exposure predicts bladder cancer survival in a US population. World J Urol 2009 0.83
42 Natural and orthogonal interaction framework for modeling gene-environment interactions with application to lung cancer. Hum Hered 2012 0.82
43 Functional genomics annotation of a statistical epistasis network associated with bladder cancer susceptibility. BioData Min 2014 0.81
44 Statistical epistasis networks reduce the computational complexity of searching three-locus genetic models. Pac Symp Biocomput 2013 0.81
45 Response to inhibition of smoothened in diverse epithelial cancer cells that lack smoothened or patched 1 mutations. Int J Oncol 2012 0.80
46 A screening-testing approach for detecting gene-environment interactions using sequential penalized and unpenalized multiple logistic regression. Pac Symp Biocomput 2015 0.78
47 Indoor and Outdoor Air Pollution and Lung Cancer in New Hampshire and Vermont. Toxicol Environ Chem 2012 0.75